Showing 31,201 - 31,220 results of 107,763 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( e ((non decrease) OR (point decrease)) ))', query time: 1.33s Refine Results
  1. 31201

    Intervention schedules. by Yuanjia Gu (12626567)

    Published 2023
    “…CFS patients are often accompanied by functional gastrointestinal diseases (FGIDs), which lead to decreased quality of life and increased fatigue. Prolong-life-with-nine-turn-method (PLWNT) is a kind of physical and mental exercise. …”
  2. 31202

    Physical-chemical properties of recycling agents. by Ying Fang (147352)

    Published 2025
    “…Moreover, the recycled asphalt with suitable BRA dosage can adapt to a wider range of traffic grades than original asphalt, and for aged matrix and SBS-modified asphalt binder, it was recommended that the reasonable dosage of BRA was 7%−9% and 3%−5%, respectively. …”
  3. 31203

    Permeation performance test results of BRA. by Ying Fang (147352)

    Published 2025
    “…Moreover, the recycled asphalt with suitable BRA dosage can adapt to a wider range of traffic grades than original asphalt, and for aged matrix and SBS-modified asphalt binder, it was recommended that the reasonable dosage of BRA was 7%−9% and 3%−5%, respectively. …”
  4. 31204

    AFM test equipment and samples. by Ying Fang (147352)

    Published 2025
    “…Moreover, the recycled asphalt with suitable BRA dosage can adapt to a wider range of traffic grades than original asphalt, and for aged matrix and SBS-modified asphalt binder, it was recommended that the reasonable dosage of BRA was 7%−9% and 3%−5%, respectively. …”
  5. 31205

    Basic technical indicators of asphalt binders. by Ying Fang (147352)

    Published 2025
    “…Moreover, the recycled asphalt with suitable BRA dosage can adapt to a wider range of traffic grades than original asphalt, and for aged matrix and SBS-modified asphalt binder, it was recommended that the reasonable dosage of BRA was 7%−9% and 3%−5%, respectively. …”
  6. 31206

    Basic technical indicators of waste soybean oil. by Ying Fang (147352)

    Published 2025
    “…Moreover, the recycled asphalt with suitable BRA dosage can adapt to a wider range of traffic grades than original asphalt, and for aged matrix and SBS-modified asphalt binder, it was recommended that the reasonable dosage of BRA was 7%−9% and 3%−5%, respectively. …”
  7. 31207

    The orthogonal test results. by Ying Fang (147352)

    Published 2025
    “…Moreover, the recycled asphalt with suitable BRA dosage can adapt to a wider range of traffic grades than original asphalt, and for aged matrix and SBS-modified asphalt binder, it was recommended that the reasonable dosage of BRA was 7%−9% and 3%−5%, respectively. …”
  8. 31208

    The orthogonal test table L<sub>16</sub> (4<sup>4</sup>). by Ying Fang (147352)

    Published 2025
    “…Moreover, the recycled asphalt with suitable BRA dosage can adapt to a wider range of traffic grades than original asphalt, and for aged matrix and SBS-modified asphalt binder, it was recommended that the reasonable dosage of BRA was 7%−9% and 3%−5%, respectively. …”
  9. 31209

    Differential scanning calorimetry tester. by Ying Fang (147352)

    Published 2025
    “…Moreover, the recycled asphalt with suitable BRA dosage can adapt to a wider range of traffic grades than original asphalt, and for aged matrix and SBS-modified asphalt binder, it was recommended that the reasonable dosage of BRA was 7%−9% and 3%−5%, respectively. …”
  10. 31210

    Extracted results of evaluation indexes. by Ying Fang (147352)

    Published 2025
    “…Moreover, the recycled asphalt with suitable BRA dosage can adapt to a wider range of traffic grades than original asphalt, and for aged matrix and SBS-modified asphalt binder, it was recommended that the reasonable dosage of BRA was 7%−9% and 3%−5%, respectively. …”
  11. 31211
  12. 31212

    Comparison of the MLTD and MDD scores of text before and after hypernym substitution using the GPT-J-6B, Programmatic+AI, and T5 approaches. by Karl Swanson (3580583)

    Published 2024
    “…<p>A) The GPT-J-6b approach reduced the mean MLTD score from 45.32 to 20.01 (<i>w</i> = 10534.5, <i>p-value</i> = 3.715x10<sup>-31</sup>) and mean MDD from 2.90 to 2.48 (<i>w</i> = 54731, <i>p-value</i> = 1.859x10<sup>-11</sup>) between text before and after hypernym substitution. …”
  13. 31213

    Evolution of Thermoelectric Properties in the Triple Cation Zintl Phase: Yb<sub>13–<i>x</i></sub>Ca<sub><i>x</i></sub>BaMgSb<sub>11</sub> (<i>x</i> = 1–6) by Christopher J. Perez (8210388)

    Published 2021
    “…The carrier concentration can be rationalized with the presence of Yb<sup>3+</sup> for all samples and decreases as a function of <i>x</i> in a systematic fashion at room temperature and increases above ∼600 K for <i>x</i> = 3–6. …”
  14. 31214

    VEGF-A siRNAs cause upregulation of phosphorylated Thr<sup>308</sup>-AKT and downregulation of Ang II and AT1R in NRK-52E cells in high glucose. by Xiaoyan Bai (554943)

    Published 2014
    “…(D) Increased pAKT (S473) and decreased Ang II and AT1R, while no effects on total AKT or pAKT (S473) mediated by VEGF-A_siRNA#1 and #2, as shown in Western blot analysis and (E) the relative quantification normalized by β-actin expression (*P<.05 vs. …”
  15. 31215

    <b>ART does not correct plasma virome and cytokine dysregulations induced by HIV-1</b> by Yingying Ma (18762652)

    Published 2024
    “…<b>Results:</b> ART resulted in an increased abundance and prevalence of human pegivirus type 1 (HPgV-1) in plasma, while slightly decrease of anellovirus diversity and abundance was observed. …”
  16. 31216
  17. 31217

    PRISMA flowchart of the included studies. by Gaelle Salame (21077899)

    Published 2025
    “…Because of the high levels of heterogeneity in the selected studies, a random-effects model was used for analysis.</p><p>The combined data showed that patients receiving immunotherapy had higher C-peptide levels (Mean Difference (MD) = 1.51; 95% Confidence Interval (CI): [-2.56, 5.58]); however, this difference was not statistically significant (p = 0.42). …”
  18. 31218

    Characteristics of Included Studies. by Gaelle Salame (21077899)

    Published 2025
    “…Because of the high levels of heterogeneity in the selected studies, a random-effects model was used for analysis.</p><p>The combined data showed that patients receiving immunotherapy had higher C-peptide levels (Mean Difference (MD) = 1.51; 95% Confidence Interval (CI): [-2.56, 5.58]); however, this difference was not statistically significant (p = 0.42). …”
  19. 31219

    Data used for the analysis. by Raphäel Rakotozandrindrainy (18389756)

    Published 2024
    “…Overall, the prevalence of schistosome infection was 55.9% (n = 2486, CI 95%: 53.3–58.5). A statistically significant association was found with age group (increased prevalence in 31–47 years old, compared to 16–20 years old (aPR = 1.15, CI 95%: 1.02–1.29) and with uptake of antimalaria preventive treatment (decreased prevalence, aPR = 0.85, CI 95%: 0.77–0.95). …”
  20. 31220

    Factors associated with schistosome infection. by Raphäel Rakotozandrindrainy (18389756)

    Published 2024
    “…Overall, the prevalence of schistosome infection was 55.9% (n = 2486, CI 95%: 53.3–58.5). A statistically significant association was found with age group (increased prevalence in 31–47 years old, compared to 16–20 years old (aPR = 1.15, CI 95%: 1.02–1.29) and with uptake of antimalaria preventive treatment (decreased prevalence, aPR = 0.85, CI 95%: 0.77–0.95). …”